Variantyx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 194

Employees

  • Latest Deal Type
  • Series D

  • Investors
  • 10

Variantyx General Information

Description

Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology. The company's platform features advanced laboratory technology, proprietary AI and machine learning analytical tools, flexible reflex testing options, and streamlined patient billing policies, enabling healthcare providers and patients to access detailed genomic analysis that supports clinical decision-making and shortens the diagnostic process.

Contact Information

Website
www.variantyx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1671 Worcester Road
  • Suite 400
  • Framingham, MA 01701
  • United States
+1 (617)
Primary Industry
Diagnostic Equipment
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • 1671 Worcester Road
  • Suite 400
  • Framingham, MA 01701
  • United States
+1 (617)

Variantyx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Variantyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series D) 01-Apr-2025 Completed Generating Revenue
10. Debt - General 01-Jan-2025 Completed Generating Revenue
9. Later Stage VC (Series D) 26-Apr-2024 Completed Generating Revenue
8. Debt - General 18-Oct-2022 Completed Generating Revenue
7. Later Stage VC (Series C2) 14-Feb-2022 Completed Generating Revenue
6. Later Stage VC (Series C) 15-Nov-2021 Completed Generating Revenue
5. Debt - PPP 02-May-2020 Completed Generating Revenue
4. Secondary Transaction - Private 20-Mar-2020 Completed Generating Revenue
3. Later Stage VC (Series B) 29-May-2019 $7M $11.8M Completed Generating Revenue
2. Early Stage VC (Series A) 28-Dec-2018 $4.8M $4.8M Completed Startup
To view Variantyx’s complete valuation and funding history, request access »

Variantyx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series D-2
Series D-1
Series C-2
Series C-1
Series C
Series B 6,206,645 $0.010000 $1.37 $1.37 1x $1.37 4.64%
Series A 3,709,246 $0.010000 $1.31 $1.31 1x $1.31 2.78%
To view Variantyx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Variantyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders
Diagnostic Equipment
Framingham, MA
194 As of 2025

Irvine, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Variantyx Competitors (17)

One of Variantyx’s 17 competitors is Agendia, a Venture Capital-Backed company based in Irvine, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agendia Venture Capital-Backed Irvine, CA
Illumina Formerly VC-backed San Diego, CA
Myriad Genetics Corporation Salt Lake City, UT
Nebula Genomics Formerly VC-backed Garden City, NY
Genomic Expression Venture Capital-Backed Beverly, MA
You’re viewing 5 of 17 competitors. Get the full list »

Variantyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Variantyx Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
OrbiMed Growth/Expansion Minority
Peregrine Ventures Venture Capital Minority
Soleus Capital Asset Manager Minority
Bosch Ventures Corporate Venture Capital Minority
GHS Investment Management (Canada) Company Corporation Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Variantyx FAQs

  • When was Variantyx founded?

    Variantyx was founded in 2014.

  • Where is Variantyx headquartered?

    Variantyx is headquartered in Framingham, MA.

  • What is the size of Variantyx?

    Variantyx has 194 total employees.

  • What industry is Variantyx in?

    Variantyx’s primary industry is Diagnostic Equipment.

  • Is Variantyx a private or public company?

    Variantyx is a Private company.

  • What is Variantyx’s current revenue?

    The current revenue for Variantyx is .

  • How much funding has Variantyx raised over time?

    Variantyx has raised $175M.

  • Who are Variantyx’s investors?

    OrbiMed, Peregrine Ventures, Soleus Capital, Bosch Ventures, and GHS Investment Management (Canada) Company are 5 of 10 investors who have invested in Variantyx.

  • Who are Variantyx’s competitors?

    Agendia, Illumina, Myriad Genetics, Nebula Genomics, and Genomic Expression are some of the 17 competitors of Variantyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process